Obesity
Abstract
Obesity is a common condition and a major cause of morbidity and mortality. Fortunately, weight loss treatment can reduce obesity-related complications. This review summarizes the evidence-based strategies physicians can employ to identify, prevent, and treat obesity, including best practices to diagnose and counsel patients, to assess and address the burden of weight-related disease including weight stigma, to address secondary causes of weight gain, and to help patients set individualized and realistic weight loss goals and an effective treatment plan. Effective treatments include lifestyle modification and adjunctive therapies such as antiobesity medications and metabolic and bariatric surgery.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Obesity Medicine Association. Obesity Medicine Algorithm. 2024. Accessed at https://obesitymedicine.org/resources/obesity-algorithm/ on 20 March 2024.
2.
National Institute for Diabetes and Digestive and Kidney Diseases. Overweight & Obesity Statistics. Accessed at www.niddk.nih.gov/health-information/health-statistics/overweight-obesity on 20 March 2024.
3.
Ryan DH, Yockey SR. Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Curr Obes Rep. 2017;6:187-194. [PMID: 28455679] doi: 10.1007/s13679-017-0262-y
4.
Loos RJF, Yeo GSH. The genetics of obesity: from discovery to biology. Nat Rev Genet. 2022;23:120-133. [PMID: 34556834] doi: 10.1038/s41576-021-00414-z
5.
Hall KD. Metabolic Adaptations to Weight Loss. Obesity (Silver Spring). 2018;26:790-791. [PMID: 29637734] doi: 10.1002/oby.22189
6.
Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628. [PMID: 7632212] doi: 10.1056/NEJM199503093321001
7.
Rosenbaum M, Hirsch J, Gallagher DA, et al. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88:906-912. [PMID: 18842775] doi: 10.1093/ajcn/88.4.906
8.
Szmygin H, Szmygin M, Cheda M, et al. Current insights into the potential role of fMRI in discovering the mechanisms underlying obesity. J Clin Med. 2023;12:4379.
9.
Sumithran P, Prendergast LA, Delbridge E, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365:1597-1604. [PMID: 22029981] doi: 10.1056/NEJMoa1105816
10.
Polidori D, Sanghvi A, Seeley RJ, et al. How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake. Obesity (Silver Spring). 2016;24:2289-2295. [PMID: 27804272] doi: 10.1002/oby.21653
11.
Curry SJ, Krist AH, Owens DK, et al; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320:1163-1171. [PMID: 30326502] doi: 10.1001/jama.2018.13022
12.
Eckel N, Li Y, Kuxhaus O, et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714-724. [PMID: 29859908] doi: 10.1016/S2213-8587(18)30137-2
13.
Garvey WT, Mechanick JI, Brett EM, et al; Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22 Suppl 3:1-203. [PMID: 27219496] doi: 10.4158/EP161365.GL
14.
de Silva VA, Suraweera C, Ratnatunga SS, et al. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16:341. [PMID: 27716110] doi: 10.1186/s12888-016-1049-5
15.
Wan Y, Tobias DK, Dennis KK, et al. Association between changes in carbohydrate intake and long term weight changes: prospective cohort study. BMJ. 2023;382:e073939. [PMID: 37758268] doi: 10.1136/bmj-2022-073939
16.
Itani O, Jike M, Watanabe N, et al. Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Med. 2017;32:246-256. [PMID: 27743803] doi: 10.1016/j.sleep.2016.08.006
17.
Tasali E, Wroblewski K, Kahn E, et al. Effect of sleep extension on objectively assessed energy intake among adults with overweight in real-life settings: a randomized clinical trial. JAMA Intern Med. 2022;182:365-374. [PMID: 35129580] doi: 10.1001/jamainternmed.2021.8098
18.
Piercy KL, Troiano RP, Ballard RM, et al. The physical activity guidelines for Americans. JAMA. 2018;320:2020-2028. [PMID: 30418471] doi: 10.1001/jama.2018.14854
19.
Jakicic JM, Powell KE, Campbell WW, et al; 2018 Physical Activity Guidelines Advisory Committee. Physical activity and the prevention of weight gain in adults: a systematic review. Med Sci Sports Exerc. 2019;51:1262-1269. [PMID: 31095083] doi: 10.1249/MSS.0000000000001938
20.
Pi-Sunyer FX, Becker DM, Bouchard C, et al. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. AmJ Clin Nutr. 1998;68:899-917.
21.
WHO Consultation on Obesity 1999: Geneva, Switzerland) & World Health Organization. (2000). Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization. 2000;894:i-xii, 1-253 https://iris.who.int/handle/10665/42330
22.
Shah NS, Luncheon C, Kandula NR, et al. Heterogeneity in obesity prevalence among Asian American adults. Ann Intern Med. 2022;175:1493-1500. [PMID: 36191316] doi: 10.7326/M22-0609
23.
WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163. [PMID: 14726171] doi: 10.1016/S0140-6736(03)15268-3
24.
Khan SS, Ning H, Wilkins JT, et al. Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3:280-287. [PMID: 29490333] doi: 10.1001/jamacardio.2018.0022
25.
Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;353:i2156. [PMID: 27146380] doi: 10.1136/bmj.i2156
26.
Bhaskaran K, dos-Santos-Silva I, Leon DA, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944-953. [PMID: 30389323] doi: 10.1016/S2213-8587(18)30288-2
27.
Narayan KM, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562-1566. [PMID: 17372155] doi: 10.2337/dc06-2544
28.
Aggarwal R, Bibbins-Domingo K, Yeh RW, et al. Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. Ann Intern Med. 2022;175:765-773. [PMID: 35533384] doi: 10.7326/M20-8079
29.
Davidson KW, Barry MJ, Mangione CM, et al; US Preventive Services Task Force. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326:736-743. [PMID: 34427594] doi: 10.1001/jama.2021.12531
30.
Teufel F, Seiglie JA, Geldsetzer P, et al. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet. 2021;398:238-248. [PMID: 34274065] doi: 10.1016/S0140-6736(21)00844-8
31.
Hussain SM, Newman AB, Beilin LJ, et al. Associations of Change in Body Size With All-Cause and Cause-Specific Mortality Among Healthy Older Adults. JAMA Netw Open. 2023;6:e237482. [PMID: 37036703] doi: 10.1001/jamanetworkopen.2023.7482
32.
Kushner RF, Batsis JA, Butsch WS, et al. Weight History in Clinical Practice: The State of the Science and Future Directions. Obesity (Silver Spring). 2020;28:9-17. [PMID: 31858735] doi: 10.1002/oby.22642
33.
Giel KE, Bulik CM, Fernandez-Aranda F, et al. Binge eating disorder. Nat Rev Dis Primers. 2022;8:16. [PMID: 35301358] doi: 10.1038/s41572-022-00344-y
34.
Buso G, Depairon M, Tomson D, et al. Lipedema: a call to action!. Obesity (Silver Spring). 2019;27:1567-1576. [PMID: 31544340] doi: 10.1002/oby.22597
35.
van der Valk ES, van den Akker ELT, Savas M, et al. A comprehensive diagnostic approach to detect underlying causes of obesity in adults. Obes Rev. 2019;20:795-804. [PMID: 30821060] doi: 10.1111/obr.12836
36.
Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403. [PMID: 11832527] doi: 10.1056/NEJMoa012512
37.
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221-2232. [PMID: 37952131] doi: 10.1056/NEJMoa2307563
38.
Wiggins T, Antonowicz SS, Markar SR. Cancer risk following bariatric surgery-systematic review and meta-analysis of national population-based cohort studies. Obes Surg. 2019;29:1031-1039. [PMID: 30591985] doi: 10.1007/s11695-018-3501-8
39.
Jensen MD, Ryan DH, Apovian CM, et al; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102-38. [PMID: 24222017] doi: 10.1161/01.cir.0000437739.71477.ee
40.
Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485-497. [PMID: 32127716] doi: 10.1038/s41591-020-0803-x
41.
Ryan L, Coyne R, Heary C, et al. Weight stigma experienced by patients with obesity in healthcare settings: A qualitative evidence synthesis. Obes Rev. 2023;24:e13606.
42.
Dickinson JK, Bialonczyk D, Reece J, et al. Person-first language in diabetes and obesity scientific publications. Diabet Med. 2023;40:e15067. [PMID: 36786059] doi: 10.1111/dme.15067
43.
Albury C, Webb H, Stokoe E, et al. Relationship between clinician language and the success of behavioral weight loss interventions: a mixed-methods cohort study. Ann Intern Med. 2023;176:1437-1447. [PMID: 37931269] doi: 10.7326/M22-2360
44.
Kahan SI. Practical strategies for engaging individuals with obesity in primary care. Mayo Clin Proc. 2018;93:351-359. [PMID: 29502565] doi: 10.1016/j.mayocp.2018.01.006
45.
Hall KD, Ayuketah A, Brychta R, et al. Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake. Cell Metab. 2019;30:226. [PMID: 31269427] doi: 10.1016/j.cmet.2019.05.020
46.
Jabbour J, Rihawi Y, Khamis AM, et al. Long term weight loss diets and obesity indices: results of a network meta-analysis. Front Nutr. 2022;9:821096. [PMID: 35479754] doi: 10.3389/fnut.2022.821096
47.
Lin SH, Cienfuegos S, Ezpeleta M, et al. Time-restricted eating without calorie counting for weight loss in a racially diverse population: a randomized controlled trial. Ann Intern Med. 2023;176:885-895. [PMID: 37364268] doi: 10.7326/M23-0052
48.
Liu D, Huang Y, Huang C, et al. Calorie restriction with or without time-restricted eating in weight loss. N Engl J Med. 2022;386:1495-1504. [PMID: 35443107] doi: 10.1056/NEJMoa2114833
49.
Astbury NM, Piernas C, Hartmann-Boyce J, et al. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes Rev. 2019;20:569-587. [PMID: 30675990] doi: 10.1111/obr.12816
50.
Karam G, Agarwal A, Sadeghirad B, et al. Comparison of seven popular structured dietary programmes and risk of mortality and major cardiovascular events in patients at increased cardiovascular risk: systematic review and network meta-analysis. BMJ. 2023;380:e072003. [PMID: 36990505] doi: 10.1136/bmj-2022-072003
51.
McLay-Cooke RT, Gray AR, Jones LM, et al. Prediction equations overestimate the energy requirements more for obesity-susceptible individuals. Nutrients. 2017;9:1012. doi: 10.3390/nu9091012
52.
Verreijen AM, Engberink MF, Memelink RG, et al. Effect of a high protein diet and/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults: a randomized controlled trial. Nutr J. 2017;16:10. [PMID: 28166780] doi: 10.1186/s12937-017-0229-6
53.
Michalopoulou M, Ferrey AE, Harmer G, et al. Effectiveness of motivational interviewing in managing overweight and obesity: a systematic review and meta-analysis. Ann Intern Med. 2022;175:838-850. [PMID: 35344379] doi: 10.7326/M21-3128
54.
Apovian CM, Aronne LJ, Bessesen DH, et al; Endocrine Society. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:342-362. [PMID: 25590212] doi: 10.1210/jc.2014-3415
55.
Wilding JPH, Batterham RL, Davies M, et al; STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553-1564. [PMID: 35441470] doi: 10.1111/dom.14725
56.
Wadden TA, Foreyt JP, Foster GD, et al. Weight loss with naltrexone sr/bupropion sr combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19:110-120. [PMID: 20559296] doi: 10.1038/oby.2010.147
57.
Wilding JPH, Batterham RL, Calanna S, et al; STEP 1 Study Group. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002. [PMID: 33567185] doi: 10.1056/NEJMoa2032183
58.
Wadden TA, Bailey TS, Billings LK, et al; STEP 3 Investigators. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial. JAMA. 2021;325:1403-1413. [PMID: 33625476] doi: 10.1001/jama.2021.1831
59.
Shi Q, Wang Y, Hao Q, et al. Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2022;399:259-269. [PMID: 34895470] doi: 10.1016/S0140-6736(21)01640-8
60.
Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27:155-161. [PMID: 14693982] doi: 10.2337/diacare.27.1.155
61.
Apovian CM, Aronne L, Rubino D, et al; COR-II Study Group. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013;21:935-943. [PMID: 23408728] doi: 10.1002/oby.20309
62.
Simon JA, Duncan C, Carmody TP, et al. Bupropion for smoking cessation: a randomized trial. Arch Intern Med. 2004;164:1797-1803. [PMID: 15364675] doi: 10.1001/archinte.164.16.1797
63.
Lewis KH, Fischer H, Ard J, et al. Safety and effectiveness of longer-term phentermine use: clinical outcomes from an electronic health record cohort. Obesity (Silver Spring). 2019;27:591-602. [PMID: 30900410] doi: 10.1002/oby.22430
64.
Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:1341-1352. [PMID: 21481449] doi: 10.1016/S0140-6736(11)60205-5
65.
Pi-Sunyer X, Astrup A, Fujioka K, et al; SCALE Obesity and Prediabetes NN8022-1839 Study Group. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11-22. [PMID: 26132939] doi: 10.1056/NEJMoa1411892
66.
Bezin J, Gouverneur A, Pénichon M, et al. GLP-1 receptor agonists and the risk of thyroid cancer. Diabetes Care. 2023;46:384-390. [PMID: 36356111] doi: 10.2337/dc22-1148
67.
Alves C, Batel-Marques F, Macedo AF. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer. Diabetes Res Clin Pract. 2012;98:271-284. [PMID: 23010561] doi: 10.1016/j.diabres.2012.09.008
68.
Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al; STEP-HFpEF Trial Committees and Investigators. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389:1069-1084. [PMID: 37622681] doi: 10.1056/NEJMoa2306963
69.
Jastreboff AM, Aronne LJ, Ahmad NN, et al; SURMOUNT-1 Investigators. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205-216. [PMID: 35658024] doi: 10.1056/NEJMoa2206038
70.
Jastreboff AM, Kushner RF. New frontiers in obesity treatment: GLP-1 and nascent nutrient-stimulated hormone-based therapeutics. Annu Rev Med. 2023;74:125-139. [PMID: 36706749] doi: 10.1146/annurev-med-043021-014919
71.
Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis. 2020;16:175-247. [PMID: 31917200] doi: 10.1016/j.soard.2019.10.025
72.
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33:3-14. [PMID: 36336720] doi: 10.1007/s11695-022-06332-1
73.
American Diabetes Association Professional Practice Committee. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S145-S57.
74.
Bramante C, Wise E, Chaudhry Z. Care of the patient after metabolic and bariatric surgery. Ann Intern Med. 2022;175:ITC65-ITC80. [PMID: 35533387] doi: 10.7326/AITC202205170
75.
Mulla CM, Middelbeek RJW, Patti ME. Mechanisms of weight loss and improved metabolism following bariatric surgery. Ann N Y Acad Sci. 2018;1411:53-64. [PMID: 28868615] doi: 10.1111/nyas.13409
76.
Arterburn D, Wellman R, Emiliano A, et al; PCORnet Bariatric Study Collaborative. comparative effectiveness and safety of bariatric procedures for weight loss: A PCORnet cohort study. Ann Intern Med. 2018;169:741-750. [PMID: 30383139] doi: 10.7326/M17-2786
77.
Wölnerhanssen BK, Peterli R, Hurme S, et al. Laparoscopic roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS). Br J Surg. 2021;108:49-57. [PMID: 33640917] doi: 10.1093/bjs/znaa011
78.
Syn NL, Cummings DE, Wang LZ, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants. Lancet. 2021;397:1830-1841. [PMID: 33965067] doi: 10.1016/S0140-6736(21)00591-2
79.
Doumouras AG, Hong D, Lee Y, et al. Association between bariatric surgery and all-cause mortality: a population-based matched cohort study in a Universal Health Care System. Ann Intern Med. 2020;173:694-703. [PMID: 32805135] doi: 10.7326/M19-3925
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 177 • Number 5 • May 2024
Pages: ITC65 - ITC80
History
Published online: 14 May 2024
Published in issue: May 2024
Keywords
Copyright
© 2024 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Obesity. Ann Intern Med.2024;177:ITC65-ITC80. [Epub 14 May 2024]. doi:10.7326/AITC202405210
Obesity. Ann Intern Med.2024;177:ITC65-ITC80. [Epub 14 May 2024]. doi:10.7326/AITC202405210
View More
Get Access
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.